Similar articles

• The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer.

  Tsihlias J, Kapusta L, Slingerland J. Tsihlias J, et al. Annu Rev Med. 1999;50:401-23. doi: 10.1146/annurev.med.50.1.401. Annu Rev Med. 1999. PMID: 10073286 Review.
• Expression of p27kip1 in prostatic adenocarcinoma.

  Cheville JC, Lloyd RV, Sebo TJ, Cheng L, Erickson L, Bostwick DG, Lohse CM, Wollan P. Cheville JC, et al. Mod Pathol. 1998 Apr;11(4):324-8. Mod Pathol. 1998. PMID: 9578081
• The cyclin-dependent kinase inhibitor p27 as a prognostic factor in advanced non-small cell lung cancer: its immunohistochemical evaluation using biopsy specimens.

  Ishihara S, Minato K, Hoshino H, Saito R, Hara F, Nakajima T, Mori M. Ishihara S, et al. Lung Cancer. 1999 Dec;26(3):187-94. doi: 10.1016/s0169-5002(99)00085-9. Lung Cancer. 1999. PMID: 10598929
• Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.

  Korkolopoulou P, Christodoulou P, Konstantinidou AE, Thomas-Tsagli E, Kapralos P, Davaris P. Korkolopoulou P, et al. Hum Pathol. 2000 Jun;31(6):751-60. doi: 10.1053/hupa.2000.8227. Hum Pathol. 2000. PMID: 10872671
• Regulation of the cdk inhibitor p27 and its deregulation in cancer.

  Slingerland J, Pagano M. Slingerland J, et al. J Cell Physiol. 2000 Apr;183(1):10-7. doi: 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I. J Cell Physiol. 2000. PMID: 10699961 Review.